Concizumab-Mtci Suppliers & Bulk Manufacturers
Available Forms: Prefilled autoinjector
Available Strengths: 60 mg/1.5 mL, 150 mg/1.5 mL, 300 mg/3 mL
Reference Brands: Alhemo (USA/EU)
Category: Plasma Products
Concizumab is a monoclonal antibody used for the routine prophylaxis of bleeding episodes in patients with hemophilia A or B, with or without inhibitors. It works by inhibiting tissue factor pathway inhibitor (TFPI), helping restore blood clotting and reduce the frequency of bleeds. The drug is administered as a subcutaneous injection using a prefilled pen. It is indicated for adolescents and adults aged 12 years and older.
Concizumab-Mtci — third party manufacturing & bulk supply
Concizumab-Mtci is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Concizumab-Mtci is supplied as Prefilled autoinjector — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Concizumab-Mtci listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Concizumab-Mtci →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Marstacimab‑Hncq
Strength:
150 mg/mL
Form: injection (prefilled syringe)
Reference Brands: Hympavzi (USA)
View Details
Emicizumab‑Kxwh
Strength:
30 mg/mL, 60 mg/0.4 mL, 105 mg/0.7 mL
Form: Injection
Reference Brands: Hemlibra (USA/EU)
View Details
Fresh Frozen Plasma (Ffp) Powder For Reconstitution Or Liquid
Strength:
available in 200-250 mL units
Form: liquid units or lyophilized (freeze-dried) powder
Reference Brands: No specific brands
View Details
Plasma Protein Fraction (Ppf) Powder
Strength:
50 mL, 250 mL, or 500 mL
Form: Lyophilized Powder or Liquid
Reference Brands: Plasmanate (US), Octaplas LG, Biotest Plasma (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
